1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …

As the coronavirus disease 2019 (COVID-19) pandemic has progressed, a large volume of
literature has developed delineating the clinical manifestations of acute infection. Recent …

Background Device-detected atrial high-rate episodes (AHREs) are atrial arrhythmias
detected by implanted cardiac devices. AHREs resemble atrial fibrillation but are rare and …

Background Alteplase is the standard agent used in early reperfusion therapy, but
alternative thrombolytic agents are needed. The efficacy and safety of reteplase as …

Importance Hospitalized patients with COVID-19 are at risk for venous and arterial
thromboembolism and death. Optimal thromboprophylaxis dosing in high-risk patients is …

Background Thrombosis and inflammation may contribute to the risk of death and
complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized …

Objective To evaluate the effects of therapeutic heparin compared with prophylactic heparin
among moderately ill patients with covid-19 admitted to hospital wards. Design Randomised …

Background The role of direct oral anticoagulants as compared with vitamin K antagonists
for atrial fibrillation after successful transcatheter aortic-valve replacement (TAVR) has not …

Background: Direct oral anticoagulants (DOACs) are preferred over warfarin for stroke
prevention in atrial fibrillation. Meta-analyses using individual patient data offer substantial …

The prevention and management of bleeding and thrombosis in patients with cirrhosis
poses several difficult clinical questions. These Clinical Practice Guidelines have been …